Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-04 Sale |
2021-06-08 8:12 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
252,500 | $46.01 | $11,616,797 | 530,960 (Indirect Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 8:12 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
200,000 | $45.55 | $9,110,689 | 1,295,830 (Indirect) |
View |
| 2021-06-02 Sale |
2021-06-04 6:52 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
14,566 | $41.52 | $604,850 | 52,154 (Indirect Direct) |
View |
| 2021-06-02 Sale |
2021-06-04 6:50 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
50,000 | $42.13 | $2,106,560 | 1,495,830 (Indirect) |
View |
| 2021-06-02 Sale |
2021-06-04 6:48 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
62,500 | $42.12 | $2,632,513 | 1,626,960 (Indirect Direct) |
View |
| 2021-05-20 Sale |
2021-05-24 8:10 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
2,000 | $41.08 | $82,159 | 66,720 (Indirect Direct) |
View |
| 2021-04-14 Sale |
2021-04-16 5:57 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
69,822 | $42.13 | $2,941,920 | 476,960 (Indirect Direct) |
View |
| 2021-04-14 Sale |
2021-04-16 5:56 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
55,714 | $42.1 | $2,345,593 | 225,030 (Indirect) |
View |
| 2021-04-12 Sale |
2021-04-14 07:52 am |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
449 | $42.32 | $19,002 | 532,858 (Indirect Direct) |
View |
| 2021-04-12 Sale |
2021-04-14 07:51 am |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
359 | $42.32 | $15,193 | 280,744 (Indirect) |
View |
| 2021-03-22 Sale |
2021-03-24 5:25 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
43,927 | $46.32 | $2,034,519 | 281,103 (Indirect) |
View |
| 2021-03-22 Sale |
2021-03-24 5:25 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
54,729 | $46.32 | $2,535,226 | 533,218 (Indirect Direct) |
View |
| 2021-03-03 Sale |
2021-03-05 7:04 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
100,000 | $44.78 | $4,478,450 | 250,390 (Indirect Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 7:03 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
125,000 | $46.94 | $5,867,148 | 576,960 (Indirect Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 7:02 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
100,000 | $46.92 | $4,692,158 | 325,030 (Indirect) |
View |
| 2021-03-02 Sale |
2021-03-04 7:00 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
100,000 | $46.94 | $4,694,090 | 350,390 (Indirect Direct) |
View |
| 2021-02-25 Purchase |
2021-02-26 7:46 pm |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
25,700 | $46.83 | $1,203,480 | 34,413 (Indirect Direct) |
View |
| 2020-12-17 Sale |
2020-12-18 2:36 pm |
Royalty Pharma plc | RPRX | ADAGE CAPITAL PARTNERS GP L.L.C. Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
7,301,050 | $43.92 | $320,672,221 | 38,714,280 (Indirect) |
View |
| 2020-10-20 Sale(A) |
2020-10-23 7:11 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
463,200 | $42 | $19,454,400 | 0 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 9:48 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
463,200 | $42 | $19,454,400 | 895,837 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-07 Conversion |
2021-05-11 9:08 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
54,670 | $0 | 211,314 (Direct) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:06 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
1,452,880 | $0 | 2,032,228 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:05 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
1,100,000 | $0 | 1,346,858 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:05 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
2,063,446 | $0 | 1,020,838 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:03 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
2,557,500 | $0 | 7,406,417 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:00 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
3,338,445 | $0 | 9,291,781 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:35 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
816 | $45.9 | 15,183 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
816 | $45.9 | 35,229 (Direct) |
View |
| 2020-12-16 Other |
2021-02-26 7:44 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
42,101 | $0 | 4,731,851 (Indirect) |
View |
| 2020-10-20 Conversion |
2021-02-26 7:44 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
640,057 | $0 | 4,731,851 (Indirect) |
View |
| 2020-06-18 Conversion(A) |
2021-02-26 7:41 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
6,270,088 | $0 | 1,113,010 (Indirect) |
View |
| 2020-12-31 Conversion |
2021-01-05 9:53 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
440,000 | $0 | 827,636 (Indirect) |
View |
| 2020-06-15 Option Award(A) |
2021-01-05 9:51 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
2,605 | $0 | 26,963 (Indirect) |
View |
| 2020-06-18 Conversion(A) |
2021-01-05 9:51 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
26,587 | $0 | 26,963 (Indirect) |
View |
Ownership(A) |
2021-01-05 9:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
0 | $0 | 26,050 (Indirect) |
View |
| 2020-12-31 Conversion |
2021-01-05 9:45 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
440,000 | $0 | 1,045,615 (Indirect) |
View |
| 2020-12-31 Conversion |
2021-01-05 9:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
550,000 | $0 | 1,315,035 (Indirect) |
View |
| 2020-12-31 Option Award |
2021-01-04 8:04 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
820 | $45.69 | 8,713 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 8:02 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
820 | $45.69 | 14,367 (Direct) |
View |
Ownership |
2020-12-31 8:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
0 | $0 | 1,638,060 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-22 9:48 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
509,520 | $0 | 895,837 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 7:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
613 | $41.17 | 7,893 (Direct) |
View |